Erika J. Crosby

CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosis

Li-Chung Tsao, Erika J. Crosby, Timothy N. Trotter et al. · JCI Insight · 2019 · 102 citations · Full text

Antibody-dependent Cellular Phagocytosis, Trastuzumab Antitumor Efficacy, Immunology +22

Engagement of NKG2D on Bystander Memory CD8 T Cells Promotes Increased Immunopathology following Leishmania major Infection

Erika J. Crosby, Michael H. Goldschmidt, E. John Wherry et al. · PLoS Pathogens · 2014 · 92 citations · Full text

Adaptive Immune System, Lcmv Immune Mice, Immunology +19

Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors

Erika J. Crosby, Jun-Ping Wei, Xiao Yang et al. · OncoImmunology · 2017 · 75 citations · Full text

Adaptive Anti-tumor Immunity, Tcr Expansion, Breast Oncology +24

Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study

Erika J. Crosby, William R. Gwin, Kimberly Blackwell et al. · Clinical Cancer Research · 2019 · 75 citations · Full text

The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment

Jason Turpin, Erika J. Crosby, Zachary C. Hartman et al. · Oncogene · 2016 · 71 citations · Full text

Erbb2δex16 Splice Variant, Breast Oncology, Major Oncogenic Driver +9